Tag: Therapeutics
Pear Therapeutics Closes Financing
Boston, MA (PRWEB) March 19, 2015 Pear Therapeutics, the creator of prescription pharmaceutical-software combination products called eFormulations™, announced today that it has successfully closed on additional financing. The funding round was led by 5AM Ventures, with several undisclosed additional investors contributing capital. The investment will allow Pear to build a portfolio of eFormulationsTM. Concurrently, Andrew […]
Global Wheezing Therapeutics Clinical Trials Review H2 2014 Report at ReportsnReports.com
Dallas, TX (PRWEB) January 03, 2015 The report “Wheezing Global Clinical Trials Review, H2, 2014″ provides data on the Wheezing clinical trial scenario. Wheezing is a whistling noise in the chest during inhalation. Wheezing occurs when the airways are narrowed or compressed. Wheezing is commonly experienced by persons with a lung disease; the most common […]
Atelectasis Therapeutics Clinical Trial Market H2 2014 Review Report at ReportsnReports.com
Dallas, TX (PRWEB) December 29, 2014 The report “Atelectasis Global Clinical Trials Review H2 2014” provides data on the Atelectasis clinical trial scenario. The report It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. Partial or complete collapse of lung is known […]
Vicus Therapeutics Announces Phase II Data Demonstrating Overall Survival Benefit with VT-122 Plus Sorafenib in Patients with Advanced Hepatocellular Carcinoma
MORRISTOWN, N.J (PRWEB) September 05, 2014 Vicus Therapeutics, an immuno-oncology company focused on bringing breakthrough immunotherapies to patients with solid-tumor cancers, announced positive results from a Phase II randomized, open-label, controlled clinical trial of its lead compound, VT-122, in combination with sorafenib, in patients with advanced hepatocellular carcinoma (HCC). In an intent-to-treat (ITT) population, investigators […]
Global Hospital Infection Therapeutics Market: Industry Analysis, Size, Share, Growth and Forecast- 2018
Albany, New York (PRWEB) July 20, 2014 Hospital acquired infections are the infections acquired by the patients following the admission in hospitals within 48 hours. These conditions are also known as nosocomial infections. The causative agents of nosocomial infections include various types of microorganisms such as bacteria (Gram-positive and Gram-negative), viruses and fungi. The most […]